Release Date: 28/12/12 15:07 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 278.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%